Pfizer's lawsuits target Metsera, its directors, and Novo Nordisk for breach of contract and antitrust violations, focusing on Novo Nordisk's acquisition proposal. The first lawsuit claims Novo ...

Scientists at UC San Diego’s Scripps Institution of Oceanography have described a new way to produce large amounts of xanthommatin, a natural pigment, in a bacterium for the first time. Xanthommatin ...

After filing one lawsuit to try to block Novo Nordisk's $9 billion effort to trump the takeover, Pfizer has returned to the courts with another, accusing Metsera and Novo Nordisk of anticompetitive ...

Pfizer filed an antitrust lawsuit on Monday accusing Danish drugmaker Novo Nordisk of structuring its $9 billion bid for ...

COPENHAGEN (Reuters) -Denmark's Novo Nordisk said on Monday it is confident that its proposed takeover of U.S. drugmaker ...

Pfizer accused Novo Nordisk of trying to stifle competition in the weight-loss market by attempting to acquire obesity startup Metsera, the second lawsuit in four days as Pfizer tries to retain its ...

The lawsuit says the merger would solidify Novo Nordisk’s market position as a leader in the field of obesity drugs by ...

Pfizer insists that Novo Nordisk’s unsolicited offer to acquire Metsera is an effort from the Danish pharma to “suppress ...

Pfizer filed its second lawsuit against Metsera and Novo Nordisk, alleging Novo Nordisk's attempt to outbid Pfizer to acquire Metsera violates antitrust laws.

What's better than investing in a stock with a promising outlook? Investing in a beaten-down stock with a promising outlook.

Pfizer Inc said on Monday it has filed a second lawsuit against drug developer Metsera , its controlling shareholder, and ...

Biotech Viking Therapeutics has gained prominence over the past two years, but it could have plenty of upside left.